Skip to content
Boustead
Boustead
BousteadBoustead
  • About Us
    • History of Boustead
    • Boustead Today
    • Milestones
    • Vision & Mission
    • Board of Directors
    • Leadership
      • Group
      • Operating Companies
  • Our Businesses
    • Pharmaceutical
    • Heavy Industries
    • Property & Industrial
      • Property Development
      • Property Management & Investment
      • Hotel Operations
      • Industrial
    • Trading, Finance & Investment
  • Act Responsibly
    • Corporate Governance
      • Board Charter
      • Directors’ Code of Ethics and Conduct
      • Audit Committee Terms of Reference
      • Risk Committee Terms of Reference
      • Nominating and Remuneration Committee Terms of Reference
      • CG Overview Statement
      • CG Report
      • Constitution
      • Diversity Policy
      • Senior Management Remuneration Policy
      • Directors Remuneration Policy
    • Integrity
      • Anti-Bribery and Corruption Policy Statement
      • Whistleblowing Policy
      • No Gift Policy
      • MACC Act Anti-Bribery Section
      • Corporate Liability Provision
  • Resource Centre
    • Media Releases
    • Gallery
    • Publications
      • Annual Reports
    • AGM / EGM
      • Summary Of Key Matters
      • Circular To Shareholders On RRPT
  • Contact Us
BousteadBoustead
  • About Us
    • History of Boustead
    • Boustead Today
    • Milestones
    • Vision & Mission
    • Board of Directors
    • Leadership
      • Group
      • Operating Companies
  • Our Businesses
    • Pharmaceutical
    • Heavy Industries
    • Property & Industrial
      • Property Development
      • Property Management & Investment
      • Hotel Operations
      • Industrial
    • Trading, Finance & Investment
  • Act Responsibly
    • Corporate Governance
      • Board Charter
      • Directors’ Code of Ethics and Conduct
      • Audit Committee Terms of Reference
      • Risk Committee Terms of Reference
      • Nominating and Remuneration Committee Terms of Reference
      • CG Overview Statement
      • CG Report
      • Constitution
      • Diversity Policy
      • Senior Management Remuneration Policy
      • Directors Remuneration Policy
    • Integrity
      • Anti-Bribery and Corruption Policy Statement
      • Whistleblowing Policy
      • No Gift Policy
      • MACC Act Anti-Bribery Section
      • Corporate Liability Provision
  • Resource Centre
    • Media Releases
    • Gallery
    • Publications
      • Annual Reports
    • AGM / EGM
      • Summary Of Key Matters
      • Circular To Shareholders On RRPT
  • Contact Us

Monthly Archives: February 2020

You are here:
  1. Home
  2. 2020
  3. February

Boustead Posts Higher Revenue of RM10.3 Bil in FY2019

Media ReleasesBy aiman.jasmin@shareinvestor.comFebruary 28, 2020

Bottom Line Impacted by Impairments & Amortisation KEY HIGHLIGHTS Revenue up by 1% to RM10.3 billion for FY2019. EBITDA for the year stood at RM441 million, a 30.7% increase from RM337.4 million in FY2018 Excluding impairments, accelerated amortisation and gain on disposal of land, the Group’s loss before taxation stood at RM128 million, marking a…

Go to Top
Boustead
  • About Us
    • History of Boustead
    • Boustead Today
    • Milestones
    • Vision & Mission
    • Board of Directors
    • Leadership
      • Group
      • Operating Companies
  • Our Businesses
    • Pharmaceutical
    • Heavy Industries
    • Property & Industrial
      • Property Development
      • Property Management & Investment
      • Hotel Operations
      • Industrial
    • Trading, Finance & Investment
  • Act Responsibly
    • Corporate Governance
      • Board Charter
      • Directors’ Code of Ethics and Conduct
      • Audit Committee Terms of Reference
      • Risk Committee Terms of Reference
      • Nominating and Remuneration Committee Terms of Reference
      • CG Overview Statement
      • CG Report
      • Constitution
      • Diversity Policy
      • Senior Management Remuneration Policy
      • Directors Remuneration Policy
    • Integrity
      • Anti-Bribery and Corruption Policy Statement
      • Whistleblowing Policy
      • No Gift Policy
      • MACC Act Anti-Bribery Section
      • Corporate Liability Provision
  • Resource Centre
    • Media Releases
    • Gallery
    • Publications
      • Annual Reports
    • AGM / EGM
      • Summary Of Key Matters
      • Circular To Shareholders On RRPT
  • Contact Us